Earlier this year, the FDA commissioner proposed something radical — payer-parti...
The next frontier in biomedicine: AI models of the human immune system, write Wa...
Access to new tools to combat RSV is likely to prove challenging this season, ex...
Medicare experts think the Biden administration’s plan for stricter nursing home...
What's on tap at HLTH, the health care industry jamboree that kicks off this wee...
The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakie...
The FDA's expert vaccine advisory panel unanimously endorsed the idea of taking ...
Listen: Is the Nobel committee evolving? Will we ever have an HIV vaccine?
Neurocrine Biosciences announced that its experimental drug for congenital adren...
In the latest edition of STAT's Health Tech newsletter: telehealth creating serv...
House Speaker candidates Reps. Steve Scalise (R-La.) and Jim Jordan (R-Ohio) hav...
Want to stay on top of the science and politics driving biotech today? Sign up t...
A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk pa...
“Sometimes we have to look for completely different chemotherapy regimens that m...
“Several ongoing trials hope to further elucidate the role of lurbinectedin in h...
African Americans have long been known to be at increased risk of kidney disease...
